原發(fā)性腎病綜合征脾腎陽虛證患者血清及尿液代謝組學(xué)的研究
[Abstract]:Objective: to investigate the potential biomarkers of (PNS) spleen and kidney yang deficiency syndrome (PNS) by using metabolic techniques to analyze the serum and urine of healthy people and patients with primary nephrotic syndrome (PNS) with spleen and kidney yang deficiency syndrome (PNS). The substance basis of TCM syndromes of PNS type of spleen and kidney yang deficiency syndrome was explored by using metabolomics technique, in order to establish the objectification and quantitative scientific expression system of TCM syndrome differentiation of PNS type of spleen and kidney yang deficiency syndrome, and to provide a new way of thinking and method for the diagnosis and treatment of PNS by traditional Chinese medicine. Methods: from May 2014 to June 2015, 25 patients with primary nephrotic syndrome and syndrome differentiation of spleen and kidney yang deficiency were studied. In addition, 25 healthy people (healthy people as family volunteers) were taken as normal control group. The samples of serum and urine (morning urine) were collected, and their sex, age, blood biochemistry, urine biochemistry and other information were recorded. The samples of serum and urine were detected by 1H-NMR, and the nuclear magnetic field data were integrated into SIMCA-P 13 software for multivariate statistical analysis. First, unsupervised principal component (PCA) analysis was used, then supervised orthogonal partial least square (O/PLS-DA) discriminant analysis was used. Based on the valid parameters of the model, the differential metabolites were confirmed according to the VIP value and load diagram (S-plot). The material basis of syndromes was obtained and the changes of metabolites in PNS syndrome of deficiency of spleen and kidney yang were explored. Results: (1) compared with the normal control group, the serum and urine composition of PNS group with spleen and kidney yang deficiency syndrome were significantly different. And there was statistical difference (P0.05). (2) according to the S-plot and VIP values of serum nuclear magnetic field data of PNS spleen and kidney yang deficiency syndrome group and normal control group, the results showed that seven endogenous metabolites had statistical difference compared with normal control group (P0.05), in which the content of lipid and pyruvate increased. However, the contents of valine, leucine N-acetylglyamine, glutamine and glycerol decreased (P0.05). (3) according to the S-plot and VIP values of urine nuclear magnetic field data of PNS group with deficiency of spleen and kidney yang and normal control group. The five endogenous metabolites were significantly different from the normal control group (P0.05). The contents of leucine, lactic acid and betaine increased, while the contents of creatinine and hippuric acid decreased (P0.05). Conclusion: compared with the normal control group, the chromatogram of nuclear magnetic metabolism in serum and urine of the patients with primary nephrotic syndrome with deficiency of spleen and kidney yang has significant difference. On the basis of principal component analysis, the differential metabolites can be separated. From the preliminary results of this study, it can be concluded that PNS spleen and kidney yang deficiency syndrome has a specific metabolic profile at the level of metabolism, mainly involving lipid, amino acid, tricarboxylic acid cycle and other metabolic disorders. But because this item did not carry on the PNS spleen and kidney yang deficiency syndrome and the PNS other syndromes metabonomics characteristic comparative research, therefore has not been able to judge which of the PNS spleen and kidney yang deficiency syndrome characteristic manifestation which belongs to the PNS common factor. The characteristic manifestation of PNS spleen-kidney yang deficiency syndrome needs to be further improved in future experiments.
【學(xué)位授予單位】:山西中醫(yī)學(xué)院
【學(xué)位級(jí)別】:碩士
【學(xué)位授予年份】:2016
【分類號(hào)】:R277.5
【參考文獻(xiàn)】
相關(guān)期刊論文 前10條
1 沈辛宜;高繼寧;;中藥聯(lián)合激素治療腎病綜合征臨床研究[J];山西醫(yī)藥雜志;2016年01期
2 郝開花;張永奎;;真武湯治療腎病綜合征90例[J];光明中醫(yī);2015年06期
3 黃宇新;趙雄;胡仕暢;胡偉雄;李強(qiáng);;腎病綜合征中西醫(yī)結(jié)合治療進(jìn)展[J];遼寧中醫(yī)藥大學(xué)學(xué)報(bào);2015年02期
4 李紅;賀娟;劉麗霞;李靖;公敏;;高繼寧教授論治健脾補(bǔ)腎法與慢性腎臟病[J];光明中醫(yī);2015年01期
5 張茵;銀永革;;腎病綜合征的治療進(jìn)展[J];醫(yī)學(xué)綜述;2014年02期
6 張靜;梁穎;張偉;孫成均;;毛細(xì)管電泳-紫外檢測(cè)法同時(shí)測(cè)定人尿中馬尿酸和甲基馬尿酸[J];分析試驗(yàn)室;2013年04期
7 陸榮華;杜玉君;;代謝組學(xué)的研究進(jìn)展及其在腎病綜合征中的應(yīng)用前景[J];中國(guó)實(shí)驗(yàn)診斷學(xué);2013年02期
8 賀娟;;高繼寧治療腎病對(duì)藥應(yīng)用經(jīng)驗(yàn)拾萃[J];山西中醫(yī);2012年12期
9 王旭方;李夢(mèng)婕;葛永純;秦衛(wèi)松;阿基業(yè);侯金花;謝紅浪;王廣基;劉志紅;;糖尿病腎病患者血清及尿液代謝組學(xué)特點(diǎn)及臨床意義[J];腎臟病與透析腎移植雜志;2012年03期
10 閆豐;宋丹;邱君思;;氟伐他汀聯(lián)合依折麥布治療慢性腎臟病2期合并高膽固醇血癥[J];臨床腎臟病雜志;2012年06期
相關(guān)博士學(xué)位論文 前1條
1 馮曉云;實(shí)驗(yàn)性糖尿病大鼠早期腎臟病變的代謝組學(xué)研究[D];第二軍醫(yī)大學(xué);2008年
,本文編號(hào):2246414
本文鏈接:http://sikaile.net/zhongyixuelunwen/2246414.html